Delivery Order SPE2DB25D3402-SPE2DB25FUGGL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,361.13 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. This competitive award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $1,554.35. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,142.17 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a completion date of December 19, 2025. The contract utilizes firm fixed price pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this order, leveraging its established position as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.97 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a $5,910.20 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which is not set-aside designated, is set to complete on July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-day supply at a ceiling value of $8,041.08. This firm fixed-price delivery order, with an ultimate completion date of December 15, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a $11,934.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a quantity of 90 units. The contract, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on December 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,846.22 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on December 12, 2025, with completion scheduled for December 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,289.56 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB25FUGGLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,705.42 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) under a firm fixed price contract. The award was issued on June 24, 2025, with an ultimate completion date of June 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion prime vendor agreement valued through December 2026 that enables the contractor to supply pharmaceuticals and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement standards through competitive awards across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 6/24/25 |